Similar articles

• Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.

  Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y; Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Iijima K, et al. Lancet. 2014 Oct 4;384(9950):1273-81. doi: 10.1016/S0140-6736(14)60541-9. Epub 2014 Jun 22. Lancet. 2014. PMID: 24965823 Clinical Trial.
• Rituximab for childhood-onset nephrotic syndrome.

  Hodson EM, Craig JC. Hodson EM, et al. Lancet. 2014 Oct 4;384(9950):1242-3. doi: 10.1016/S0140-6736(14)60654-1. Epub 2014 Jun 22. Lancet. 2014. PMID: 24965824 No abstract available.
• Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.

  Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K. Ito S, et al. Pediatr Nephrol. 2013 Feb;28(2):257-64. doi: 10.1007/s00467-012-2319-1. Epub 2012 Oct 10. Pediatr Nephrol. 2013. PMID: 23052656
• Rituximab for childhood refractory nephrotic syndrome.

  Iijima K. Iijima K. Pediatr Int. 2011 Oct;53(5):617-621. doi: 10.1111/j.1442-200X.2011.03432.x. Pediatr Int. 2011. PMID: 21771179 Review.
• Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials.

  Iijima K, Sako M, Kamei K, Nozu K. Iijima K, et al. Pediatr Nephrol. 2018 Sep;33(9):1449-1455. doi: 10.1007/s00467-017-3746-9. Epub 2017 Jul 17. Pediatr Nephrol. 2018. PMID: 28717938 Free PMC article. Review.